BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28698296)

  • 1. PRKCI promotes immune suppression in ovarian cancer.
    Sarkar S; Bristow CA; Dey P; Rai K; Perets R; Ramirez-Cardenas A; Malasi S; Huang-Hobbs E; Haemmerle M; Wu SY; McGuire M; Protopopov A; Jiang S; Liu JF; Hirsch MS; Chang Q; Lazar AJ; Sood AK; Drapkin R; DePinho R; Draetta G; Chin L
    Genes Dev; 2017 Jun; 31(11):1109-1121. PubMed ID: 28698296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PKCι regulates nuclear YAP1 localization and ovarian cancer tumorigenesis.
    Wang Y; Justilien V; Brennan KI; Jamieson L; Murray NR; Fields AP
    Oncogene; 2017 Jan; 36(4):534-545. PubMed ID: 27321186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent copy number gains drive PKCι expression and PKCι-dependent oncogenic signaling in human cancers.
    Liu Y; Justilien V; Fields AP; Murray NR
    Adv Biol Regul; 2020 Dec; 78():100754. PubMed ID: 32992230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addiction to protein kinase Cɩ due to PRKCI gene amplification can be exploited for an aptamer-based targeted therapy in ovarian cancer.
    Rehmani H; Li Y; Li T; Padia R; Calbay O; Jin L; Chen H; Huang S
    Signal Transduct Target Ther; 2020 Aug; 5(1):140. PubMed ID: 32820156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification of PRKCI, located in 3q26, is associated with lymph node metastasis in esophageal squamous cell carcinoma.
    Yang YL; Chu JY; Luo ML; Wu YP; Zhang Y; Feng YB; Shi ZZ; Xu X; Han YL; Cai Y; Dong JT; Zhan QM; Wu M; Wang MR
    Genes Chromosomes Cancer; 2008 Feb; 47(2):127-36. PubMed ID: 17990328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome 3q26 Gain Is an Early Event Driving Coordinated Overexpression of the PRKCI, SOX2, and ECT2 Oncogenes in Lung Squamous Cell Carcinoma.
    Liu Y; Yin N; Wang X; Khoor A; Sambandam V; Ghosh AB; Fields ZA; Murray NR; Justilien V; Fields AP
    Cell Rep; 2020 Jan; 30(3):771-782.e6. PubMed ID: 31968252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine Oviductal High-Grade Serous Carcinomas Mirror the Genomic Alterations, Gene Expression Profiles, and Immune Microenvironment of Their Human Counterparts.
    McCool KW; Freeman ZT; Zhai Y; Wu R; Hu K; Liu CJ; Tomlins SA; Fearon ER; Magnuson B; Kuick R; Cho KR
    Cancer Res; 2020 Feb; 80(4):877-889. PubMed ID: 31806642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Significance of
    Hashimoto I; Sakamaki K; Oue N; Kimura Y; Hiroshima Y; Hara K; Maezawa Y; Kano K; Aoyama T; Yamada T; Yamamoto N; Ogata T; Ito H; Shiozawa M; Morinaga S; Rino Y; Yasui W; Masuda M; Miyagi Y; Oshima T
    Anticancer Res; 2019 Oct; 39(10):5715-5720. PubMed ID: 31570472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRKCI negatively regulates autophagy via PIK3CA/AKT-MTOR signaling.
    Qu L; Li G; Xia D; Hongdu B; Xu C; Lin X; Chen Y
    Biochem Biophys Res Commun; 2016 Feb; 470(2):306-312. PubMed ID: 26792725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells.
    Horikawa N; Abiko K; Matsumura N; Hamanishi J; Baba T; Yamaguchi K; Yoshioka Y; Koshiyama M; Konishi I
    Clin Cancer Res; 2017 Jan; 23(2):587-599. PubMed ID: 27401249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.
    Yang J; Zhou Y; Ng SK; Huang KC; Ni X; Choi PW; Hasselblatt K; Muto MG; Welch WR; Berkowitz RS; Ng SW
    BMC Cancer; 2017 Jun; 17(1):422. PubMed ID: 28623900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical protein kinase C{iota} is required for bronchioalveolar stem cell expansion and lung tumorigenesis.
    Regala RP; Davis RK; Kunz A; Khoor A; Leitges M; Fields AP
    Cancer Res; 2009 Oct; 69(19):7603-11. PubMed ID: 19738040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of circ-PRKCI inhibits cell migration and proliferation in Hirschsprung disease by suppressing the expression of miR-1324 target PLCB1.
    Zhou L; Li Y; Jiang W; Zhang H; Wen Z; Su Y; Wu F; Zhi Z; Shen Q; Li H; Xu X; Tang W
    Cell Cycle; 2018; 17(9):1092-1101. PubMed ID: 29895226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression.
    Barger CJ; Zhang W; Hillman J; Stablewski AB; Higgins MJ; Vanderhyden BC; Odunsi K; Karpf AR
    Oncotarget; 2015 Sep; 6(29):27613-27. PubMed ID: 26243836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant expression of JNK-associated leucine-zipper protein, JLP, promotes accelerated growth of ovarian cancer.
    Ha JH; Yan M; Gomathinayagam R; Jayaraman M; Husain S; Liu J; Mukherjee P; Reddy EP; Song YS; Dhanasekaran DN
    Oncotarget; 2016 Nov; 7(45):72845-72859. PubMed ID: 27655714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of atypical protein kinase C (PKCι and PKCζ) and its relationship with yes-associated protein in lung adenocarcinoma.
    Kim KH; Chung C; Kim JM; Lee D; Cho SY; Lee TH; Cho HJ; Yeo MK
    BMC Cancer; 2019 Aug; 19(1):804. PubMed ID: 31412817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism.
    Phillips E; Lang V; Bohlen J; Bethke F; Puccio L; Tichy D; Herold-Mende C; Hielscher T; Lichter P; Goidts V
    Int J Cancer; 2016 Oct; 139(8):1776-87. PubMed ID: 27299852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of the immune microenvironment in ovarian cancer patients.
    Yang L; Wang S; Zhang Q; Pan Y; Lv Y; Chen X; Zuo Y; Hao D
    Mol Omics; 2018 Oct; 14(5):341-351. PubMed ID: 30129640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian Cancer-Intrinsic Fatty Acid Synthase Prevents Anti-tumor Immunity by Disrupting Tumor-Infiltrating Dendritic Cells.
    Jiang L; Fang X; Wang H; Li D; Wang X
    Front Immunol; 2018; 9():2927. PubMed ID: 30619288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.